Clinical Trial Update: Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety, tolerability, pharmacodynamics, and efficacy of CNP-104 in subjects with Primary Biliary Cholangitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• CNP-104

Snippet

Sponsor: COUR Pharmaceutical Development Company, Inc. | Conditions: Primary Biliary Cholangitis | Phase 1, Phase 2 | Status: COMPLETED